{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:28:36Z","timestamp":1785241716844,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/22488-3"],"award-info":[{"award-number":["2016\/22488-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ebiom.2019.04.029","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T17:03:15Z","timestamp":1556038995000},"page":"370-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis"],"prefix":"10.1016","volume":"43","author":[{"given":"Eloi M.","family":"Lago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos P.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talita G.","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana F.","family":"Mazloum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcius C.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo U.","family":"Carna\u00faba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro L.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson A.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo L.G.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano D.","family":"Andricopulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josu\u00e9","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2019.04.029_bb0005","first-page":"681","article-title":"Schistosomiasis and soil-transmitted helminthiases: numbers of people treated in 2017","volume":"50","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0010","first-page":"4","article-title":"Schistosomiasis","volume":"9","author":"McManus","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4155\/fmc-2017-0112","article-title":"Antischistosomal agents: state of art and perspectives","volume":"10","author":"Lago","year":"2018","journal-title":"Fut Med Chem"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0020","first-page":"24","article-title":"Praziquantel for schistosomiasis: single-drug metabolism revisited, mode of action, and resistance","volume":"5","author":"Vale","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0025","article-title":"Schistosome vaccines for domestic animals","volume":"3","author":"You","year":"2018","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.pt.2014.04.009","article-title":"Chasing helminths and their economic impact on farmed ruminants","volume":"30","author":"Charlier","year":"2014","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0035","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.pt.2016.08.002","article-title":"Discovery of novel antischistosomal agents by molecular modeling approaches","volume":"32","author":"Mafud","year":"2016","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0040","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.drudis.2013.11.005","article-title":"Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines","volume":"19","author":"Jin","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/bph.13895","article-title":"Drug repurposing screens and synergistic drug combinations for infectious diseases","volume":"175","author":"Zheng","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/bph.14081","article-title":"Inventing new therapies without reinventing the wheel: the power of drug repurposing","volume":"175","author":"Papapetropoulos","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0055","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nm.2758","article-title":"A high-throughput drug screen for Entamoeba histolytica indentifies a new lead and target","volume":"18","author":"Debnath","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0060","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1504022112","article-title":"Auranofin exerts broad-spectrum bactericidal activitiesby targeting thiol-redox homeostasis","volume":"112","author":"Harbut","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0065","doi-asserted-by":"crossref","first-page":"282ra49","DOI":"10.1126\/scitranslmed.3010286","article-title":"Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection","volume":"7","author":"He","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0070","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1473-3099(19)30005-2","article-title":"Drugs and vaccines in the 21st century for neglected diseases","volume":"19","author":"Ferreira","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0080","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3390\/ph3051530","article-title":"Nonsteroidal anti-inflammatory drugs (NSAIDs): progress in small molecule drug development","volume":"3","author":"Rao","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0085","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ijantimicag.2014.06.018","article-title":"Schistosomicidal effect of the anti-inflammatory drug diclofenac and its structural correlation with praziquantel","volume":"44","author":"Carvalho","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0090","series-title":"Current topics in tropical medicine","first-page":"333","article-title":"Antischistosomal natural compounds: present challenges for new drug screens","author":"de Moraes","year":"2012"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0095","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.tiv.2014.12.014","article-title":"Garcinielliptone FC: antiparasitic activity without cytotoxicity to mammalian cells","volume":"29","author":"Silva","year":"2015","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0100","doi-asserted-by":"crossref","first-page":"6648","DOI":"10.1128\/AAC.01371-15","article-title":"Antischistosomal activity of oxindolimine-metal complexes","volume":"59","author":"de Moraes","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0105","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.phymed.2015.06.009","article-title":"Cardamonin, a schistosomicidal chalcone from Piper aduncum L. (Piperaceae) that inhibits Schistosoma mansoni ATP diphosphohydrolase","volume":"22","author":"de Castro","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tiv.2018.02.012","article-title":"Antiparasitic, structural, pharmacokinetic, and toxicological properties of riparin derivatives","volume":"50","author":"Mafud","year":"2018","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cbi.2015.12.003","article-title":"Structural parameters, molecular properties, and biological evaluation of some terpenes targeting Schistosoma mansoni parasite","volume":"244","author":"Mafud","year":"2016","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003656","article-title":"Anthelmintic activity in vivo of epiisopiloturine against juvenile and adult worms of Schistosoma mansoni","volume":"9","author":"Guimar\u00e3es","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0125","doi-asserted-by":"crossref","first-page":"e0196667","DOI":"10.1371\/journal.pone.0196667","article-title":"Epiisopilosine alkaloid has activity against Schistosoma mansoni in mice without acute toxicity","volume":"13","author":"Guimar\u00e3es","year":"2018","journal-title":"Plos One"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0130","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ijantimicag.2017.06.005","article-title":"Antiparasitic activity of nerolidol in a mouse model of schistosomiasis","volume":"50","author":"Silva","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0135","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2217\/nnm-2017-0308","article-title":"Self-nanoemulsifying drug-delivery systems improve oral absorption and antischistosomal activity of epiisopiloturine","volume":"13","author":"Lima","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4269\/ajtmh.1962.11.201","article-title":"New approach to the screening of drugs in experimental schistosomiasis mansoni in mice","volume":"11","author":"Pellegrino","year":"1962","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0145","first-page":"397","article-title":"A simple device for quantitative stool thick-smear 366 technique in Schistosoma mansoni","volume":"14","author":"Katz","year":"1972","journal-title":"Rev Inst Med Trop"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0150","doi-asserted-by":"crossref","first-page":"e2617","DOI":"10.1371\/journal.pntd.0002617","article-title":"A diterpene alcohol from chlorophyll, as a drug against neglected tropical disease schistosomiasis mansoni","volume":"8","author":"de Moraes","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0155","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.drudis.2006.10.005","article-title":"Similarity-based virtual screening using 2D fingerprints","volume":"11","author":"Willett","year":"2006","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0160","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.biopha.2016.12.057","article-title":"Synergistic effects of in vitro combinations of piplartine, epiisopiloturine and praziquantel against Schistosoma mansoni","volume":"88","author":"Campelo","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tiv.2017.07.021","article-title":"Cyclohexene-fused 1,3-oxazines with selective antibacterial and antiparasitic action and low cytotoxic effects","volume":"44","author":"de Brito","year":"2017","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0170","doi-asserted-by":"crossref","first-page":"e01722-18","DOI":"10.1128\/AAC.01722-18","article-title":"Spironolactone as an antischistosomal drug capable of clinical repurposing: in vitro and in vivo studies","volume":"63","author":"Guerra","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0175","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/VIII.suppl_1.7","article-title":"Experimental observations on flufenamic, mefenamic, and meclofenamic acids","volume":"VIII","author":"Winder","year":"1966","journal-title":"Rheumatology"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0002-9343(86)90077-X","article-title":"Pharmacology of diclofenac sodium","volume":"80","author":"Scholer","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4269\/ajtmh.2004.71.206","article-title":"Lack of evidence for an antischistosomal activity of myrrh in experimental animals","volume":"71","author":"Botros","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0190","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.drudis.2013.07.001","article-title":"Phenotypic screens as a renewed approach for drug discovery","volume":"18","author":"Zheng","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0195","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrd4336","article-title":"The discovery of first-in-class drugs: origins and evolution","volume":"13","author":"Eder","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0200","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd2144","article-title":"Innovative lead discovery strategies for tropical diseases","volume":"5","author":"Nwaka","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0205","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nm1737","article-title":"Identification of oxadiazoles as new drug leads for the control of schistosomiasis","volume":"14","author":"Sayed","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0210","first-page":"118","article-title":"Artemether and praziquantel: origin, mode of action, impact, and suggested application for effective control of human schistosomiasis","volume":"1","author":"Bergquist","year":"2018","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0215","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1586\/ecp.13.15","article-title":"The potential and promise of mefenamic acid","volume":"6","author":"Cimolai","year":"2013","journal-title":"Expert Rev Clin Phamacol"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1744806918770320","article-title":"Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs for patients with primary dysmenorrhea: a network meta-analysis","volume":"14","author":"Feng","year":"2018","journal-title":"Mol Pain"},{"issue":"7\u201316","key":"10.1016\/j.ebiom.2019.04.029_bb0225","first-page":"1966","article-title":"Experimental observations on flufenamic, mefenamic, and meclofenamic acids. I. Pharmacology","author":"Winder","year":"1966","journal-title":"Ann Phys Med"},{"issue":"Suppl","key":"10.1016\/j.ebiom.2019.04.029_bb0230","first-page":"23","article-title":"Experimental observations on flufenamic, mefenamic and meclofenamic acids. 3. Metabolic disposition","author":"Glazko","year":"1966","journal-title":"Ann Phys Med"},{"key":"10.1016\/j.ebiom.2019.04.029_bb0235","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419302683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419302683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:58:41Z","timestamp":1762455521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419302683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":47,"alternative-id":["S2352396419302683"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.04.029","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}